Article

Iain Conn, a former CEO of Centrica and an executive with extensive experience at BP, is being considered as a potential chairman of IP Group, the science investment firm. A decision is anticipated from IP Group's board before the year's end. The firm has backed several notable companies, including Hinge Health and Oxford Nanopore, and recently reported declines in the value of its holdings due to funding delays and pricing pressures.